Camurus AB (CAMRF)
56.80
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Camurus Profit Margin (Quarterly): 26.97% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 26.97% |
| June 30, 2024 | 16.68% |
| March 31, 2024 | 19.97% |
| December 31, 2023 | -4.06% |
| September 30, 2023 | 22.50% |
| June 30, 2023 | 44.70% |
| March 31, 2023 | 20.71% |
| December 31, 2022 | 4.88% |
| September 30, 2022 | 14.50% |
| June 30, 2022 | 3.63% |
| March 31, 2022 | -0.34% |
| December 31, 2021 | -7.67% |
| September 30, 2021 | -4.00% |
| June 30, 2021 | -35.09% |
| March 31, 2021 | -17.37% |
| December 31, 2020 | -62.02% |
| September 30, 2020 | -20.23% |
| June 30, 2020 | -24.68% |
| March 31, 2020 | -124.9% |
| December 31, 2019 | -205.2% |
| September 30, 2019 | -156.2% |
| Date | Value |
|---|---|
| June 30, 2019 | -735.7% |
| March 31, 2019 | -365.7% |
| December 31, 2018 | -1.12K% |
| September 30, 2018 | -223.7% |
| June 30, 2018 | -922.9% |
| March 31, 2018 | -247.8% |
| December 31, 2017 | -956.2% |
| September 30, 2017 | -418.0% |
| June 30, 2017 | -239.3% |
| March 31, 2017 | -234.1% |
| December 31, 2016 | -74.90% |
| September 30, 2016 | -43.28% |
| June 30, 2016 | -79.55% |
| March 31, 2016 | -95.90% |
| December 31, 2015 | -87.64% |
| September 30, 2015 | -61.07% |
| June 30, 2015 | -508.3% |
| March 31, 2015 | 17.44% |
| December 31, 2014 | 51.68% |
| September 30, 2014 | -4.57% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-205.2%
Minimum
Dec 2019
44.70%
Maximum
Jun 2023
-16.55%
Average
-2.17%
Median
Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -1.45K% |
| BioInvent International AB | -761.8% |
| Hansa Biopharma AB | -213.3% |
| BioArctic AB | -137.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.41% |
| Return on Assets | 9.64% |
| Return on Invested Capital | 11.41% |
| Gross Profit Margin (Quarterly) | 93.01% |
| Operating Margin (Quarterly) | 29.57% |
| Return on Net Operating Assets | 20.13% |